James Mezhir Surgical Oncology Laboratory

  • Recent Publications

    1: Mezhir JJ, McDowell BD. Pancreaticobiliary surgery for the treatment of
    malignancy: spread the word. J Surg Res. 2013 Dec;185(2):513-5. doi:
    10.1016/j.jss.2012.09.018. Epub 2012 Sep 27. PubMed PMID: 23043864.

    2: Hrabe JE, Byrn JC, Button AM, Zamba GK, Kapadia MR, Mezhir JJ. A matched
    case-control study of IBD-associated colorectal cancer: IBD portends worse
    outcome. J Surg Oncol. 2013 Oct 16. doi: 10.1002/jso.23465. [Epub ahead of print]
    PubMed PMID: 24132737.

    3: Kaminsky PM, Mezhir JJ. Intraperitoneal drainage after pancreatic resection: a
    review of the evidence. J Surg Res. 2013 Oct;184(2):925-30. doi:
    10.1016/j.jss.2013.05.092. Epub 2013 Jun 19. PubMed PMID: 23866787.

    4: Crago AM, Denton B, Salas S, Dufresne A, Mezhir JJ, Hameed M, Gonen M, Singer
    S, Brennan MF. A prognostic nomogram for prediction of recurrence in desmoid
    fibromatosis. Ann Surg. 2013 Aug;258(2):347-53. doi:
    10.1097/SLA.0b013e31828c8a30. PubMed PMID: 23532110.

    5: Muniz VP, Askeland RW, Zhang X, Reed SM, Tompkins VS, Hagen J, McDowell BD,
    Button A, Smith BJ, Weydert JA, Mezhir JJ, Quelle DE. RABL6A Promotes Oxaliplatin
    Resistance in Tumor Cells and Is a New Marker of Survival for Resected Pancreatic
    Ductal Adenocarcinoma Patients. Genes Cancer. 2013 Jul;4(7-8):273-84. doi:
    10.1177/1947601913501074. PubMed PMID: 24167655; PubMed Central PMCID:

    6: Mezhir JJ, Posner MC, Roggin KK. Prospective clinical trial of diagnostic
    peritoneal lavage to detect positive peritoneal cytology in patients with gastric
    cancer. J Surg Oncol. 2013 Jun;107(8):794-8. doi: 10.1002/jso.23328. Epub 2013
    Mar 26. PubMed PMID: 23532564.

    7: Mezhir JJ. Optimizing pancreatectomy outcomes: follow the evidence. J Surg
    Res. 2013 May;181(2):213-5. doi: 10.1016/j.jss.2012.02.038. Epub 2012 Mar 10.
    PubMed PMID: 22459286.

    8: Sun RC, Button AM, Smith BJ, Leblond RF, Howe JR, Mezhir JJ. A comprehensive
    assessment of transfusion in elective pancreatectomy: risk factors and
    complications. J Gastrointest Surg. 2013 Apr;17(4):627-35. doi:
    10.1007/s11605-013-2169-6. Epub 2013 Feb 20. PubMed PMID: 23423430.

    9: Mezhir JJ, Fourman LT, Do RK, Denton B, Allen PJ, D'Angelica MI, DeMatteo RP,
    Fong Y, Jarnagin WR. Changes in the management of benign liver tumours: an
    analysis of 285 patients. HPB (Oxford). 2013 Feb;15(2):156-63. doi:
    10.1111/j.1477-2574.2012.00556.x. Epub 2012 Sep 21. PubMed PMID: 23297727; PubMed
    Central PMCID: PMC3719923.

    10: Mezhir JJ. Management of complications following pancreatic resection: an
    evidence-based approach. J Surg Oncol. 2013 Jan;107(1):58-66. doi:
    10.1002/jso.23139. Epub 2012 Apr 25. Review. PubMed PMID: 22535571.

    11: Mezhir JJ, Shia J, Riedel E, Temple LK, Nash GM, Weiser MR, Paty PB, Wong WD,
    Guillem JG. Whole-mount pathologic analysis of rectal cancer following
    neoadjuvant therapy: implications of margin status on long-term oncologic
    outcome. Ann Surg. 2012 Aug;256(2):274-9. doi: 10.1097/SLA.0b013e31825c13d5.
    PubMed PMID: 22791103.

    12: Abu-Hejleh T, Mezhir JJ, Goodheart MJ, Halfdanarson TR. Incidence and
    management of gastrointestinal perforation from bevacizumab in advanced cancers.
    Curr Oncol Rep. 2012 Aug;14(4):277-84. doi: 10.1007/s11912-012-0238-8. Review.
    PubMed PMID: 22532266.

    13: Dahdaleh FS, Calva-Cerqueira D, Carr JC, Liao J, Mezhir JJ, O'Dorisio TM,
    Howe JR. Comparison of clinicopathologic factors in 122 patients with resected
    pancreatic and ileal neuroendocrine tumors from a single institution. Ann Surg
    Oncol. 2012 Mar;19(3):966-72. doi: 10.1245/s10434-011-1997-4. Epub 2011 Aug 16.
    PubMed PMID: 21845496.

    14: Place TL, Mezhir JJ. Molecular characterization of desmoid tumors: decryption
    of the enigma. Onkologie. 2012;35(11):641-2. doi: 10.1159/000344005. Epub 2012
    Oct 22. PubMed PMID: 23147539.

    15: Case AJ, Mezhir JJ, O'Leary BR, Hrabe JE, Domann FE. Rational design of a
    secreted enzymatically inactive mutant of extracellular superoxide dismutase.
    Redox Rep. 2012;17(6):239-45. doi: 10.1179/1351000212Y.0000000028. PubMed PMID:
    23339859; PubMed Central PMCID: PMC3569055.